Here, we posit a preliminary perspective that SCCs divided mostly by convenience via anatomical origin are in fact distinct from other cancers and consistent within in their genetic alterations, including determinants of squamous differentiation TP63 and SOX2 and the antioxidant response regulator Nrf2, that ultimately coordinate oncogenic and metabolic pathways to drive antioxidant generation. This evidence concerns the gene TP63 and cancer.